Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy

Farshad Heydari, Maryam Feli, Mohsen Maleknia, Zeinab Habibi, Armin Sohrabi, Michael R. Hamblin, Jalal Naghinezhad

Open source

DOI
10.1007/s12012-026-10104-z
Published
2026-02-24
Container
Cardiovascular Toxicology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12012-026-10104-z,
  title = {Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy},
  author = {Farshad Heydari and Maryam Feli and Mohsen Maleknia and Zeinab Habibi and Armin Sohrabi and Michael R. Hamblin and Jalal Naghinezhad},
  year = {2026},
  journal = {Cardiovascular Toxicology},
  doi = {10.1007/s12012-026-10104-z},
  url = {https://doi.org/10.1007/s12012-026-10104-z}
}

RIS

TY  - JOUR
TI  - Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy
AU  - Farshad Heydari
AU  - Maryam Feli
AU  - Mohsen Maleknia
AU  - Zeinab Habibi
AU  - Armin Sohrabi
AU  - Michael R. Hamblin
AU  - Jalal Naghinezhad
PY  - 2026
JO  - Cardiovascular Toxicology
DO  - 10.1007/s12012-026-10104-z
UR  - https://doi.org/10.1007/s12012-026-10104-z
ER  - 

APA

Heydari, F., Feli, M., Maleknia, M., Habibi, Z., Sohrabi, A., Hamblin, M. R., & Naghinezhad, J. (2026). Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-026-10104-z

Source records